loading page

Endotype clustering in chronic rhinosinusitis based on the chemokine expression pattern
  • +5
  • Ulrike Förster-Ruhrmann,
  • Greta Pierchalla,
  • Agnieszka Szczepek,
  • Joachim Fluhr,
  • Metin Artuc,
  • Torsten Zuberbier,
  • Claus Bachert,
  • Heidi Olze
Ulrike Förster-Ruhrmann
Charité Universitätsmedizin Berlin
Author Profile
Greta Pierchalla
Charité Universitätsmedizin Berlin
Author Profile
Agnieszka Szczepek
Charite Universitatsmedizin Berlin
Author Profile
Joachim Fluhr
Charité Universitätsmedizin Berlin
Author Profile
Metin Artuc
Charité Universitätsmedizin Berlin
Author Profile
Torsten Zuberbier
Charité Universitätsmedizin Berlin
Author Profile
Claus Bachert
University Hospital Ghent
Author Profile
Heidi Olze
Charité Universitätsmedizin Berlin
Author Profile

Abstract

Background: Chronic rhinosinusitis with and without nasal polyps (CRSwNP/ CRSsNP) is an inflammatory disease affecting the nasal and sinus mucosal lining. Here, to further characterize this heterogeneous disease, we performed an extended endotyping of CRS using the nasal tissue from CRS-patients and a new approach of expression profiling of chemokines related to Th2-type cytokine IL-5. Methods: In this case-control study, we included 66 patients with CRS (CRSwNP n=26; CRSsNP n=40) diagnosed according to the EPOS 2020 criteria. The control group (n=25) consisted of CRS-free patients scheduled for inferior turbinate surgery. The concentration of following chemokines and cytokines was determined in tissue samples obtained during routine surgery from all subjects: TARC/ CCL17, PARC/ CCL18, eotaxin/ CCL11, MCP-3/ CCL7, MIP-1α/ CCL3, IP-10/ CXCL10, ENA-78/ CCL5, and IL-5. The analysis was performed by partition-based clustering. Results: In CRS tissues, the concentration of eotaxin, TARC, total IgE, IL-5, and ECP was significantly higher than in control (p<0.005). The analysis identified seven clusters. Cluster-1 was IL-5- and inflammatory chemokines-negative (11% CRSwNP). Cluster-2 had low IL-5 concentration and elevated MCP-3/CCL7 (100% CRSsNP). Clusters -3 and -4 expressed IP-10/CXCL10 (type-1-dominated), TARC/CCL17 and eotaxin/CCL11 (both type-2-dominated) (CRSwNP 13-31%). Clusters 5-7 had high concentration of IL-5, TARC/ CCL17, PARC/ CCL18, and eotaxin/CCL11 (type-2-dominated), NP 71-100%, asthma 19-50%, N-ERD 29%. Conclusions: Our chemokine expression-based extended analysis identified distinct CRS endotype clusters, possibly impacting future diagnosis, monitoring, and biologics-based treatment of CRS.